The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
1.4% of the total share capital traded today, reasonable amount when you look a the limited loose change shares not held by the institutions. Let’s hope that it’s directors buys and an RNS drops.
I would have thought 65p is fair value currently until we know more, valuing the company at 30m. It’s conservative based on the slowdown and the cost headwinds. However, it was bought by the PE guys for 50 million just over a year ago and then spun for a ludicrous 150m a few months later. The market tends to get these valuations right over time, however it’s far too cheap currently.
Relax Karlo! It’s a share discussion bulletin, I’m sharing an opinion and actions based on my thoughts. You don’t have to acknowledge, you can choose to ignore. No need to get worked up….not worth it. Good luck with your buy.
you claim to have bought 1% of the company. I bought 10000 shares yesterday as I saw these on the top list but I don't have to come on pretending I'm some sort of big hitting dude trying to ramp the stock by saying this would be a good synergy with my company. Perhaps have the username Deborah Meedan to really test the bulls--- alerters out. Jeez!
I suspect if you tried to buy 1% now it would move northwards somewhat. Agree with what you say but no larger holder has sold significantly as no notification of going below 5%. I suspect they are licking wounds for the capital loss but have the same views as us and see value on a medium term view. Don’t forget they bought at the IPO price less than a year ago seeing value at that level. Much of the headwinds were already apparent, they are just lasting longer than was thought.
That said, will buy more if they drop it again, would happily accumulate circa 5% as an under the radar buyer. Fits very nicely with my Company and can see some synergy.
I’ve bought another 0.3% so now hold 1%. Bought from the low to 28 ish pence which has moved us back to 29.5p so I don’t thinnk there is much floating about and certainly non of the large shareholders wanting out at these depressed levels to mop my buys up. Very happy with the 1% I have…..I will sit on these now as it’s just too low even with the possibility of cash raise or being taken private again. The market for this Company as a high end niche player is growing, it will still cost to get the market share but £100m sales really does look very achievable in the medium term.
Agreed, there is obviously a float to sell. I own a similar business and the headwinds are difficult currently, the exchange rate is also not helping. However, whilst the IPO price was too high, this is now valued at £14m. It’s priced for a medium to long term economic issue with potentially a raise required at a later date. They are small enough to navigate there way through this, demand will remain regardless of the financial squeeze due to the bespoke nature of the product. This is turning over £44m, I see £100m in 3-5 years and a likely EBITDA of at least 10%. A PE of 15 would bring it back to its IPO price of £150m. This is not a start up, it’s been around for a while and is in a good market place. It may need some more cash to realise it’s objectives fully but it’s a good 2-3 yr punt. I only worry it gets taken out on the cheap.
Well I’ve just bought 0.7% of the company if that helps?!
Difficult conditions that will improve. Showing ok sales growth, niche player, small and nimble enough to navigate the way forward. PE of 5 is too low, could well get swallowed up as a very nice bolt on.
Hoping it has bottomed out now - rereading the RNS seems to me good prospect of things improving from here in the medium term, and I think on that perspective oversold.
I've bought a few today - keeping some money back in case falls further, and looking to next year really, especially with macro economic conditions swirling around
All indices across the Atlantic saw massive reversal this evening & EU/UK futures looking good too, I am expecting many UK stocks to gap up at the opening today and to see good recovery through out the day
A bog roll inscribed with Seraphine 20 to be used by the BOD urgently when share price hits 20p
International Personal Finance PLC - Leeds, England-based company which offers small, unsecured cash loans - Revenue for 2021 falls to GBP548.7 million from GBP661.3 million in 2020, though firm swings to pretax profit of GBP67.7 million from loss of GBP40.7 million. This is due to impairment charge reducing to GBP56.2 million from GBP250.1 million in 2020. Declares final dividend of 5.8 pence, bringing full-year total to 8.0p versus nothing in 2020. Credit issued amounts to GBP982.1 million in 2021, up from GBP772.2 million in 2020. "Looking ahead, we intend to meet increasing customer demand and accelerate customer receivables growth by further investing in our technology, and product and channel development so consumers can access our credit offerings in a way that suits them, whether that be through our customer representative service or digitally," says Chief Executive Gerard Ryan. Shares end 10% higher in London.
Seraphine Group PLC - London-based maternity and nursing wear maker and retailer - Expects full-year revenue "marginally" below market forecasts and adjusted earnings before interest, tax, depreciation and amortisation "significantly" below expectations at around GBP4.5 million. Reports strong sales growth in 17 weeks to January 30, up 45% at constant exchange rates with growth in North America at 69%. However, says February to date has been a soft month. March is expected to be better, with the traditionally stronger month expected to see e-commerce demand recover. "Looking to FY23, we expect sales growth of 25-30% and Ebitda margins to start to rebuild," company says. Stock tumbles 67% in London on Wednesday.
I see looks like the MM's heard me ASK gone up and the the book has flipped from 1v2 to 2v1 hopefully should see a steady rise and gap up tomorrow
Good Luck all !!
Anyone know what the MM's are playing at? Full ask getting hammered and buys flooding in yet ask is not moving one iota?
Me to nice to see L2 sea of Blue
Only way is up from here big overreaction and clearly bottomed out
BUMP Richard Leonard's pick
PIWORLD interview at 53m39s
https://www.piworld.co.uk/education-videos/piworld-interview-with-richard-leonard-winners-and-losers-of-2021/